Events
Search Results
WSGR Events
5.14.26
Biotech's New Playbook: Spinouts and Optionality
Biotechnology companies are increasingly using single-asset spinouts as a way to create value, though the approach can be complex. This afternoon forum will examine considerations to strategically design and execute a successful spinout. Attendees will gain insight into the legal foundations of these transactions, including tax considerations, patent strategy, IP allocation, and structural design. The program will also explore the broader business drivers behind spinout decisions—such as capital formation, strategic focus, partnership alignment, governance, and long-term value creation.
Affiliated Programs
5.14.26
Life Science Gateway 2026 Seattle and Japan
Wilson Sonsini is proud to support Life Science Gateway 2026 Seattle and Japan, hosted by SNBL Global Gateway (SGG), Seattle Children’s Research Institute, and Kobe City. This two-day event will offer multiple keynotes, panel discussions, and pitch sessions, exploring investment trends, regulations, and the technologies shaping the future of healthcare industry.
WSGR Events
10.27.25
The Power Table - An Exclusive Retreat for Female Life Sciences VC Partners
Wilson Sonsini and Banc of California hosts a select group of women partners in life sciences venture capital for a private retreat designed to foster connection, insight, and renewal. This intimate gathering offers a unique space to step away from the demands of day-to-day investing and engage in candid conversations, peer learning, and strategic exchange with fellow partners shaping the future of healthcare and biotechnology.
Affiliated Programs
10.15.25
Asians in Life Sciences: Strategies for Success in Uncertain Times
Wilson Sonsini is pleased to support the Asians in Life Sciences program, which will begin with a fireside chat with Marian Nakada, Life Sciences Advisor and Past Investor, JJDC, and followed by a panel discussion moderated by Life Sciences Corporate Partner Jennifer Fang, "Asians in Life Sciences: Strategies for Success in Uncertain Times." Panelists include Eunice Chapon, Director, Impact, BrightEdge - American Cancer Society; Amanda Chen, Vice President, Investments, Vertex Ventures HC; Vinit Nijhawan, Managing Director, MassVentures; Chong Xu, Partner, F-Prime Capital; and Sabrina Yang, Vice President, Global Initiatives, Flagship Pioneering.
Affiliated Programs
2.26.25
Frontiers Summit 2025
Wilson Sonsini is a proud sponsor of Phase Capital's Frontiers Summit. This national event brings together investors, founders, and industry experts to discuss trends, success stories, and transformative ideas at the intersection of Healthcare, AI, and Space, who are driving the next wave of innovation.
WSGR Events
10.09.24
Wilson Sonsini Biotech Summit
We invite you to join us for Wilson Sonsini's inaugural Biotech Summit on October 9-10, 2024. This unique event will bring together leaders from across the biotech industry, including esteemed researchers, policymakers, prominent investors, and CEOs. Over two impactful days, we will host an intimate CEO dinner, as well as expert panel discussions covering key topics such as antitrust issues, FDA insights, and venture capital trends. Be a part of enriching conversations about strategic collaborations designed to foster innovation in treatments, advancements for patients, and value for companies within the biotech sector.
WSGR Events
6.13.24
Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference
Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.
Affiliated Programs
5.06.24
SynBioBeta 2024: The Global Synthetic Biology Conference
Wilson Sonsini is proud to sponsor SynBioBeta 2024: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Join us for an unparalleled four-day summit delving into synthetic biology. Explore why the costs of reading, writing, and editing DNA plummet while speed and accessibility soar. Gain insights into cutting-edge medical advancements such as cell therapies, vaccines, and living medicines. Discover how companies harness biology to produce bio-based jet fuel, textiles, concrete, and other chemicals and materials. Engage with trailblazing entrepreneurs crafting innovative foods, crops, and fragrances. Join us to see the potential applications of these technologies in shaping sustainable manufacturing ecosystems.
Affiliated Programs
3.28.24
Athena's Spring CXO Forum
Wilson Sonsini Goodrich & Rosati is pleased to support Athena's Spring CXO Forum. Athena's CXO Spring Forum creates a safe harbor exclusively for executive STEM women looking to optimize this circle of influence, renew coveted relationships, and share business resources directly from those running, leading, or launching STEM companies. In this intimate gathering, co-sponsored with JLL, we’ll delve into table discussions spanning the Corporate Transparency Act, trends in remote workplace dynamics, and other business challenges. Expect to exchange experiences and perspectives over a three-course dinner and take away new avenues to navigate the evolving market landscape.
Speaking Engagements
2.29.24
What’s Hot and What’s Not in Venture Investing
Wilson Sonsini Goodrich & Rosati is pleased to support Biocom’s Global Life Science Partnering Conference. This year, our life sciences corporate partner Karen Deschaine will moderate the panel "What’s Hot and What’s Not in Venture Investing," panelists include Jay Lichter, Avalon BioVentures; Jeremy Caldwell, Red Tree VC; Carole Neuchterlein, Roche Venture Fund; Carolyn Ng, TPG; and Uwe Schoenbeck, Canaan.